| Literature DB >> 33801941 |
Juliana Gomez1, Zammam Areeb1, Sarah F Stuart1, Hong P T Nguyen1, Lucia Paradiso1, Ahmad Zulkifli1, Sonakshi Madan1, Vijay Rajagopal2, Magdalene K Montgomery3, Hui K Gan4, Andrew M Scott4, Jordan Jones1,5, Andrew H Kaye1,6, Andrew P Morokoff1,5, Rodney B Luwor1.
Abstract
Reticulocalbin 1 (RCN1) is an endoplasmic reticulum (ER)-residing protein, involved in promoting cell survival during pathophysiological conditions that lead to ER stress. However, the key upstream receptor tyrosine kinase that regulates RCN1 expression and its potential role in cell survival in the glioblastoma setting have not been determined. Here, we demonstrate that RCN1 expression significantly correlates with poor glioblastoma patient survival. We also demonstrate that glioblastoma cells with expression of EGFRvIII receptor also have high RCN1 expression. Over-expression of wildtype EGFR also correlated with high RCN1 expression, suggesting that EGFR and EGFRvIII regulate RCN1 expression. Importantly, cells that expressed EGFRvIII and subsequently showed high RCN1 expression displayed greater cell viability under ER stress compared to EGFRvIII negative glioblastoma cells. Consistently, we also demonstrated that RCN1 knockdown reduced cell viability and exogenous introduction of RCN1 enhanced cell viability following induction of ER stress. Mechanistically, we demonstrate that the EGFRvIII-RCN1-driven increase in cell survival is due to the inactivation of the ER stress markers ATF4 and ATF6, maintained expression of the anti-apoptotic protein Bcl-2 and reduced activity of caspase 3/7. Our current findings identify that EGFRvIII regulates RCN1 expression and that this novel association promotes cell survival in glioblastoma cells during ER stress.Entities:
Keywords: EGFRvIII; ER stress; RCN1; apoptosis; glioblastoma
Year: 2021 PMID: 33801941 PMCID: PMC7999088 DOI: 10.3390/cancers13061198
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639